Home › NDC Lookup › RxCUI directory › RxCUI 1946842

Abemaciclib 150 MG Oral Tablet — RxCUI 1946842

RxNorm drug concept · Semantic clinical drug
RxCUI 1946842 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1946842
Official nameAbemaciclib 150 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped8
Reported Medicaid activity (SDUD)27,007 prescriptions · 48 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Abemaciclib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No, it's approved for a specific type: hormone receptor-positive (HR-positive), HER2-negative breast cancer in adults. It can be used for early-stage cancer at high risk of coming...
  • What exactly does Verzenio treat — is it for all types of breast cancer?
  • Diarrhea is the most common side effect and it usually starts in the first week. The key is to act fast: at the very first loose stool, start an antidiarrheal like loperamide (Imod...
  • I've heard diarrhea is really bad with this medicine — what should I do?
📖 Read our full Abemaciclib guide →

🕸️ Concept Web — How Abemaciclib 150 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Abemaciclib 150 MG Oral Tablet RxCUI 1946842

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Abemaciclib 1946825
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Verzenio 1946831
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Abemaciclib Oral Tablet 1946829
    • Abemaciclib Oral Product 1946827
    • Abemaciclib Pill 1946828
    • Abemaciclib Oral Tablet [Verzenio] 1946833
    • Verzenio Oral Product 1946834
    • Verzenio Pill 1946835
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Abemaciclib 150 MG SCDC · 1946841
  • Abemaciclib Oral Tablet SCDF · 1946829
  • Abemaciclib Oral Product SCDG · 1946827
  • Abemaciclib Pill SCDG · 1946828

Brand-Name Concepts

  • Abemaciclib 150 MG Oral Tablet [Verzenio] SBD · 1946844
  • Abemaciclib 150 MG [Verzenio] SBDC · 1946843
  • Abemaciclib Oral Tablet [Verzenio] SBDF · 1946833
  • Verzenio Oral Product SBDG · 1946834
  • Verzenio Pill SBDG · 1946835
  • Verzenio BN · 1946831

📦 FDA Products & Package NDCs

4 products · 8 package NDCs
8 package NDCs map to RxCUI 1946842 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00002-4483-54 1 BLISTER PACK in 1 CARTON (0002-4483-54) / 14 TABLET in 1... Verzenio Eli Lilly and Company 2017-10-06
00002-4483-62 2 BLISTER PACK in 1 CARTON (0002-4483-62) / 14 TABLET in 1... Verzenio Eli Lilly and Company 2025-02-15
00002-4815-54 1 BLISTER PACK in 1 CARTON (0002-4815-54) / 14 TABLET in 1... Verzenio Eli Lilly and Company 2017-10-06
00002-4815-62 2 BLISTER PACK in 1 CARTON (0002-4815-62) / 14 TABLET in 1... Verzenio Eli Lilly and Company 2025-02-15
00002-5337-54 1 BLISTER PACK in 1 CARTON (0002-5337-54) / 14 TABLET in 1... Verzenio Eli Lilly and Company 2017-10-06
00002-5337-62 2 BLISTER PACK in 1 CARTON (0002-5337-62) / 14 TABLET in 1... Verzenio Eli Lilly and Company 2025-02-15
00002-5337-63 1 CARTON in 1 CARTON (0002-5337-63) / 4 BLISTER PACK in 1 C... Verzenio Eli Lilly and Company 2020-03-05
00002-6216-54 1 BLISTER PACK in 1 CARTON (0002-6216-54) / 14 TABLET in 1... Verzenio Eli Lilly and Company 2017-10-06
Observed labelers: Eli Lilly and Company (8) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.